STAT1 and colorectal carcinoma: In this context, it would be interesting to explore whether butyrate can also be involved in the absence of STAT1 activation partially helping to inhibit PD-L1 expression in CRC, thereby enhancing the cytotoxicity of T-cells to tumor cells.